CanadaPMS-QUETIAPINE 50 mg tablets (quetiapine fumarate), DIN 02361892, lots 658180 and 658181, from Pharmascience Inc. are affected. They were recalled because the quetiapine content is out of specification; verify if your product is one of the affected lots, consult your healthcare provider before discontinuing use, contact Pharmascience Inc. with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Pharmascience Inc., 100 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4.
How to identify it
Brand: Pharmascience Inc.; Product Name: PMS-QUETIAPINE; Market Authorization: DIN 02361892; Dosage Form: Tablet; Strength: QUETIAPINE (QUETIAPINE FUMARATE) 50mg; Lot: 658180, 658181
The hazard
The content (quetiapine) is out of specification in the affected batches.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)